GSK (GSK)

Up
Share Price:
1,864.00p
Market Cap:
£75,407m
Change Today:
9.50p
Sector:
Pharma and Biotech

Latest ShareCast News

GSK highlights pipeline momentum with Ris‑Rez phase III success, Jideytro first‑line efficacy

By Iain Gilbert

Date: Monday 14 Sep 2026

(Sharecast News) - Drugmaker GSK reported two major advances in its oncology pipeline on Monday, as new data showed its B7‑H3 antibody‑drug conjugate Ris‑Rez delivered a significant survival benefit in relapsed small cell lung cancer, while registrational results for Jideytro supported a potential move into first‑line ROS1‑positive non‑small cell lung cancer.

GSK gets Japanese approval for new ready‑to‑use shingles vaccine format

By Iain Gilbert

Date: Thursday 10 Sep 2026

(Sharecast News) - Drugmaker GSK said on Thursday that Japan's Ministry of Health, Labour and Welfare has approved a prefilled syringe version of its shingles vaccine Shingrix, offering a simpler, ready‑to‑use presentation for healthcare professionals.

GSK advances mRNA flu shot after Phase II success

By Iain Gilbert

Date: Tuesday 01 Sep 2026

(Sharecast News) - Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III after reporting positive Phase II results at the OPTIONS XIII influenza conference.

GSK notches major regulatory milestones in Japan... 24-Aug-2026
GSK launches £2bn cost savings drive, confirms ... 28-Jul-2026
GSK secures EMA review for single‑dose Bex... 20-Jul-2026
GSK shares fall as cough drug development axed 17-Jul-2026
GSK rectal cancer drug shows positive result in ... 13-Jul-2026
GSK hails 'milestone' drug trial results in China 10-Jul-2026
GSK's momelotinib receives orphan drug designati... 12-Jun-2026
GSK to buy Boston-based biopharma firm Nuvalent ... 09-Jun-2026
Trials show GSK drug cures hepatitis B in nearly... 28-May-2026
Citi sees buying opportunity at AstraZeneca afte... 18-May-2026
GSK strikes agreement with China's SBP Group, la... 11-May-2026
Sales jump at GSK on strong demand for specialty... 29-Apr-2026
GSK hepatitis B drug secures FDA priority review 28-Apr-2026
US court rules against GSK in dispute with Anapt... 27-Apr-2026
GSK's Blenrep gets green light from China's NMPA 20-Apr-2026
GSK ovarian, womb cancer drug posts positive res... 13-Apr-2026
GSK's Exdensur gets green light from Chinese reg... 08-Apr-2026
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

GSK Market Data

Currency UK Pounds
Price 1,864.00p
Change Today 9.50p
52 Week High 2,208.00p
52 Week Low 1,470.50p
Volume 115,521
Shares Issued 4,045.42m
Market Cap £75,407m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
Not Available
Price Trend
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Income
Not Available
Growth
Not Available
Price Chg 6m
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
Not Available
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
Not Available